Jdrf

Following eight-year ‘pilot experiment’ in Italy, the firm’s Biovelocita now builds companies across Europe

Plus: Abata draws strategic investment from BMS as it preps first human study in multiple sclerosis

Viking, Celldex, Janux offerings top list of follow-ons; Denali, Crinetics, Avidity among those raising PIPEs

Plus fresh cash for Halia and Neophore, and a new spinout from venture-backed Cumulus Oncology

After eight years advancing academic projects in country with relative dearth of management, veteran VC now seeking ‘pan-European’ goals

Plus: Novartis’ iptacopan shows benefit in IgA nephropathy and updates from Mirum, Lexeo, Rocket, Lilly, Syndax, SAB, Amicus and Pneumagen

Plus: Ottesen becomes CMO at Adcendo, and updates from Splice Bio, Shape, C4 and more

Plus: 15% weight reduction for Boehringer, Zealand Phase II asset and updates from Aviko, DiogenX, Syneos, OliX and more

Sanofi acquiring Provention for $2.9B to take over Type I diabetes launch, advance disease interception pipeline

In second M&A deal this year, Patient Square-backed Kriya adds epilepsy, trigeminal neuralgia programs along with platform in ‘nine-digit’ acquisition